Dan Gilbert Funds NF Cure After Losing Son at 26

A father who couldn't save his son is now funding the cure that could save thousands of others.

Billionaire Dan Gilbert, owner of the Cleveland Cavaliers, lost his oldest son Nick in 2023 after a 21-year battle with neurofibromatosis. The rare genetic disorder causes tumors to grow on nerve tissue, affecting roughly 1 in 2,000 births in the United States.

Nick was just five when doctors found a tumor on his optic nerve. What followed were decades of chemotherapy, radiation, and major surgeries that punctuated his childhood and young adulthood.

Near the end of his life, a rapidly growing tumor on Nick's brainstem robbed him of his ability to breathe, hear, and see properly. He died at 26, leaving behind a father with unlimited resources but no medical options left to try.

Gilbert faced a truth that money couldn't change: there was no cure. Now the Chairman of Rocket Companies is determined to ensure no other parent faces that same helpless moment.

The Ripple Effect

Through the Gilbert Family Foundation, Gilbert invests approximately $50 million each year into medical research focused on neurofibromatosis and other rare diseases. An annual Detroit benefit event recently raised a record-breaking $12 million in a single night, bringing hundreds of donors into the fight.

That funding has already changed lives. As a longtime partner of the Children's Tumor Foundation, Gilbert's philanthropy directly supported research that led to the first two FDA-approved treatments for inoperable NF tumors.

While these treatments came too late for Nick, they've given hope to families just beginning their journey with the disease. Children diagnosed today have options that didn't exist when Nick first got sick.

Gilbert calls Nick his hero and has made good on other promises too. He recently opened Gilly's Clubhouse, a Detroit sports bar his son dreamed up before his death, creating a gathering place that keeps Nick's spirit alive.

The foundation's work extends beyond lab research into clinical trials, patient support, and connecting families navigating the same devastating diagnosis the Gilberts once faced. Each dollar funds the science Gilbert believes will eventually eliminate neurofibromatosis entirely.

A father's grief is fueling a medical revolution that could spare countless families from saying goodbye too soon.